2021
DOI: 10.4103/ijrc.ijrc_18_20
|View full text |Cite
|
Sign up to set email alerts
|

Lung Transplantation for Idiopathic Pulmonary Fibrosis: A Narrative Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 50 publications
1
1
0
Order By: Relevance
“…Complications reported in acute care were consistent with other reports of patients with COVID‐19, including respiratory failure, hematologic complications, rheumatologic complications, weakness, and renal failure 33,35–37 . Postoperative complications were also consistent with reported complications of patients who underwent BOLT for reasons other than COVID‐19, including infection, pneumothorax, bleeding, renal failure, and weakness 8,34,38,39 . Acute hospital readmissions from IPR are seen among non‐COVID‐19 lung transplant patients with variable readmission rates that can range from 19–40% 8,12 .…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…Complications reported in acute care were consistent with other reports of patients with COVID‐19, including respiratory failure, hematologic complications, rheumatologic complications, weakness, and renal failure 33,35–37 . Postoperative complications were also consistent with reported complications of patients who underwent BOLT for reasons other than COVID‐19, including infection, pneumothorax, bleeding, renal failure, and weakness 8,34,38,39 . Acute hospital readmissions from IPR are seen among non‐COVID‐19 lung transplant patients with variable readmission rates that can range from 19–40% 8,12 .…”
Section: Discussionsupporting
confidence: 79%
“…33,[35][36][37] Postoperative complications were also consistent with reported complications of patients who underwent BOLT for reasons other than COVID-19, including infection, pneumothorax, bleeding, renal failure, and weakness. 8,34,38,39 Acute hospital readmissions from IPR are seen among non-COVID-19 lung transplant patients with variable readmission rates that can range from 19-40%. 8,12 It is not surprising that this patient population had a greater percentage of readmission rates to acute care (47%) given the greater medical complexity of these patients compared to those not infected with COVID-19.…”
Section: Medical Complicationsmentioning
confidence: 99%